Eisai Clinches Merck Deal to Develop and Sell Cancer Drug, Shares Soar Eisai Clinches Merck Deal to Develop and Sell Cancer Drug, Shares Soar

Merck& Co Inc and Japan ' s Eisai Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Eisai ' s cancer drug Lenvima, which is already approved in dozens of countries for two uses.Reuters Health Information
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news